Cited by 280Ovarian cancer diagnosis and treatmentBRCA gene mutations in cancerCervical Cancer and HPV Research

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Modeling high-grade serous ovarian carcinogenesis from the fallopian tube

Open access

Karst, Alison M., Levanon, Keren, Drapkin, Ronny·2011·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1017300108PMC PMC3088633

Open this paper in CoChat — free account

Abstract

High-grade serous ovarian carcinoma (HGSOC) is a lethal disease for which improved screening and treatment strategies are urgently needed. Progress in these areas is impeded by our poor understanding of HGSOC pathogenesis. Most ovarian cancer research is based on the hypothesis that HGSOC arises from ovarian surface epithelial cells. However, recent studies suggest that >50% of high-grade serous carcinomas involving the ovary likely arise from fallopian tube epithelium. Therefore, limiting HGSOC research to modeling based on ovarian surface epithelium alone is inadequate. To address the need for a fallopian tube-based model of HGSOC, we have developed a system for studying human fallopian tube secretory epithelial cell (FTSEC) transformation. Our model is based on (i) immortalization of FTSECs isolated from primary samples of normal, nondiseased human fallopian tubes, (ii) transformation of FTSECs with defined genetic elements, and (iii) xenograft-based tumorigenic assays. We use our model to show that FTSECs immortalized with human telomerase reverse transcriptase (hTERT) plus SV40 large T and small T antigens are transformed by either oncogenic Ras (H-Ras(V12)) or c-Myc expression, leading to increased proliferation, clonogenicity, and anchorage-independent growth. Additionally, we demonstrate that FTSECs remain susceptible to c-Myc-mediated transformation in the absence of viral oncoproteins, by replacing SV40 large T and small T antigens with sh-p53, mutant CDK4 (CDK4(R24C)), and sh-PP2A-B56γ. Importantly, all transformed FTSECs gave rise to high-grade Müllerian carcinomas that were grossly, histologically, immunophenotypically, and genomically similar to human HGSOC. With this model, we will now be able to assess the transformative effects of specific genetic alterations on FTSECs in order to characterize their respective roles in HGSOC development.

Integrity signals

Registry

Crossref · 10.1073/pnas.1017300108

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cancer statistics, 2009
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,890
Ras oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467
The biology of ovarian cancer: new opportunities for translation
Bast, R. C., Hennessy, B. T., & Mills, G. B. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2644 · Cited by 1,372
Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship
Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C. M., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,114
The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome
Medeiros, F., Muto, M. G., Lee, Y., Elvin, J. A., Callahan, M. J., Feltmate, C. M., Garber, J. E., Cramer, D. W., & Crum, C. P. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000180854.28831.77 · Cited by 913
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Lee, Y., Miron, A., Drapkin, R., Nucci, M. R., Medeiros, F., Saleemuddin, A., Garber, J. E., Birch, C., Mou, H., Gordon, R., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2091 · Cited by 904
Self-citation
Grading Ovarian Serous Carcinoma Using a Two-Tier System
Malpica, A. L., Deavers, M. T., Lu, K. H., Bodurka, D. C., Atkinson, E. N., Gershenson, D. M., & Silva, E. G. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200404000-00009 · Cited by 671
Ovarian Low-grade and High-grade Serous Carcinoma
Vang, R., Shih, I., & Kurman, R. J. (2009) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181b4fffa · Cited by 562

Flagged first, then by citations

Show all 37 references

Sorted by citations

Items 101–200 of 279

The Molecular Fingerprint of High Grade Serous Ovarian Cancer Reflects Its Fallopian Tube Origin
Kessler, M., Fotopoulou, C., & Meyer, T. F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14046571 · Cited by 43
Three-dimensional modeling of ovarian cancer
White, E. A., Kenny, H. A., & Lengyel, E. R. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.07.003 · Cited by 43
Molecular Profiling and Clinical Outcome of High-Grade Serous Ovarian Cancer Presenting with Low- versus High-Volume Ascites
Feigenberg, T., Clarke, B. A., Virtanen, C., Plotkin, A., Letarte, M., Rosen, B. P., Bernardini, M. Q., Kollara, A., Brown, T. J., & Murphy, K. J. (2014) · BioMed Research International · doi:10.1155/2014/367103 · Cited by 42
Intra-Tumoral Nerve-Tracing in a Novel Syngeneic Model of High-Grade Serous Ovarian Carcinoma
Barr, J. L., Kruse, A., Restaino, A. C., Tulina, N. M., Stückelberger, S., Vermeer, S. J., Williamson, C. S., Vermeer, D. W., Madeo, M., Stamp, J., et al. (2021) · Cells · doi:10.3390/cells10123491 · Cited by 41
Self-citation
Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer
Konstantinopoulos, P. A., & Matulonis, U. A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00296 · Cited by 42
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors
Elias, K. M., Tsantoulis, P. K., Tille, J., Vitonis, A. F., Doyle, L. A., Hornick, J. L., Kaya, G., Barnes, L., Cramer, D. W., Puppa, G., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5161 · Cited by 42
Self-citation
The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer
Luo, L. Y., Kim, E., Cheung, H. W., Weir, B. A., Dunn, G. P., Shen, R. R., & Hahn, W. C. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0407 · Cited by 43
Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model
Karthikeyan, S., Russo, A., Dean, M., Lantvit, D. D., Endsley, M. P., & Burdette, J. E. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.003 · Cited by 40
miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling
Knarr, M., Avelar, R. A., Sekhar, S. C., Kwiatkowski, L. J., Dziubinski, M. L., McAnulty, J., Skala, S. L., Avril, S., Drapkin, R., & DiFeo, A. V. (2020) · Nature Communications · doi:10.1038/s41467-020-17030-w · Cited by 42
Self-citation
Tumorigenesis and peritoneal colonization from fallopian tube epithelium
Eddie, S. L., Quartuccio, S. M., hAinmhire, E. Ó., Moyle-Heyrman, G., Lantvit, D., Wei, J., Vanderhyden, B. C., & Burdette, J. E. (2015) · Oncotarget · doi:10.18632/oncotarget.3985 · Cited by 39
Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications
Shan, W., Mercado‐Uribe, I., Zhang, J., Rosen, D. G., Zhang, S., Wei, J., & Liu, J. (2012) · Cell Cycle · doi:10.4161/cc.20544 · Cited by 38
NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach
Bekos, C., Muqaku, B., Dekan, S., Horvat, R., Polterauer, S., Gerner, C., Aust, S., & Pils, D. (2019) · Cancers · doi:10.3390/cancers11050698 · Cited by 37
Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: An immunohistochemical study of tubal and Müllerian antigens
Esselen, K. M., Ng, S., Hua, Y., White, M., Jimenez, C. A., Welch, W. R., Drapkin, R., Berkowitz, R. S., & Ng, S. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.12.007 · Cited by 37
Self-citation
The Role of Opportunistic Bilateral Salpingectomy vs Tubal Occlusion or Ligation for Ovarian Cancer Prophylaxis
Ely, L. K., & Truong, M. (2017) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2017.01.001 · Cited by 36
AMPK-Independent LKB1 Activity Is Required for Efficient Epithelial Ovarian Cancer Metastasis
Buensuceso, A. V., Ramos-Valdes, Y., DiMattia, G. E., & Shepherd, T. G. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0530 · Cited by 35
Revisiting ovarian cancer preclinical models: Implications for a better management of the disease
Ricci, F., Broggini, M., & Damia, G. L. M. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.01.005 · Cited by 35
Testing ovarian cancer cell lines to train dogs to detect ovarian cancer from blood plasma: A pilot study
Murarka, M., Vesley-Gross, Z. I., Essler, J. L., Smith, P. G., Hooda, J., Drapkin, R., & Otto, C. M. (2019) · Journal of Veterinary Behavior · doi:10.1016/j.jveb.2019.04.010 · Cited by 35
Self-citation
Most Commonly Mutated Genes in High-Grade Serous Ovarian Carcinoma Are Nonessential for Ovarian Surface Epithelial Stem Cell Transformation
Yamulla, R. J., Nalubola, S., Flesken‐Nikitin, A., Nikitin, A. Y., & Schimenti, J. C. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108086 · Cited by 35
The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence
Wesley, T., Berzins, S. P., Kannourakis, G., & Ahmed, N. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00726-x · Cited by 36
Three-dimensional modeling of the human fallopian tube fimbriae
Eddie, S. L., Quartuccio, S. M., Zhu, J., Shepherd, J. A., Kothari, R., Kim, J. J., Woodruff, T. K., & Burdette, J. E. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.015 · Cited by 35
Multispectral fluorescence imaging of human ovarian and fallopian tube tissue for early-stage cancer detection
Tate, T. H., Baggett, B. K., Rice, P. F. S., Koevary, J. W., Orsinger, G. V., Nymeyer, A. C., Welge, W. A., Saboda, K., Roe, D. J., Hatch, K. D., et al. (2016) · Journal of Biomedical Optics · doi:10.1117/1.jbo.21.5.056005 · Cited by 36
UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
Hardy, L. R., Salvi, A., & Burdette, J. E. (2018) · Cancers · doi:10.3390/cancers10080262 · Cited by 34
Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer
Lepage, C. C., Palmer, M. C. L., Farrell, A. C., Neudorf, N. M., Lichtensztejn, Z., Nachtigal, M. W., & McManus, K. J. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01317-w · Cited by 40
FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis
Levanon, K., Sapoznik, S., Bahar‐Shany, K., Brand, H., Shapira‐Frommer, R., Korach, J., Hirsch, M. S., Roh, M. H., Miron, A., Liu, J. F., et al. (2013) · Oncogene · doi:10.1038/onc.2013.394 · Cited by 34
Self-citation
Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention
Chiyoda, T., Hart, P. C., Eckert, M. A., McGregor, S. M., Lastra, R. R., Hamamoto, R., Nakamura, Y., Yamada, S. D., Olopade, O. I., Lengyel, E. R., et al. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0281 · Cited by 33
A dog oviduct-on-a-chip model of serous tubal intraepithelial carcinoma
Ferraz, M. D. A. M. M., Nagashima, J. B., Venzac, B., Gac, S. L., & Songsasen, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-58507-4 · Cited by 34
Organoids of the Female Reproductive Tract: Innovative Tools to Study Desired to Unwelcome Processes
Heremans, R., Jan, Ž., Timmerman, D., & Vankelecom, H. E. J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.661472 · Cited by 36
Mutated p53 in HGSC—From a Common Mutation to a Target for Therapy
Saleh, A., & Perets, R. (2021) · Cancers · doi:10.3390/cancers13143465 · Cited by 33
TP53 loss initiates chromosomal instability in fallopian tube epithelial cells
Bronder, D., Wangsa, D., Zong, D., Meyer, T. J., Wardenaar, R., Minshall, P., Tighe, A., Hirsch, D. D., Heselmeyer‐Haddad, K., Nelson, L., et al. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.049001 · Cited by 29
Lineage specific extracellular vesicle-associated protein biomarkers for the early detection of high grade serous ovarian cancer
Trinidad, C. V., Pathak, H. B., Cheng, S., Tzeng, S., Madan, R., Sardiu, M. E., Bantis, L. E., Deighan, C., Jewell, A., Rayamajhi, S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-44050-5 · Cited by 31
Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients
He, J., Liu, Y., Zhang, L., & Zhang, H. (2018) · Medical Science Monitor · doi:10.12659/msm.911518 · Cited by 32
Mechanisms of High-Grade Serous Carcinogenesis in the Fallopian Tube and Ovary: Current Hypotheses, Etiologic Factors, and Molecular Alterations
Otsuka, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094409 · Cited by 31
Imaging Mass Spectrometry Reveals Crosstalk between the Fallopian Tube and the Ovary that Drives Primary Metastasis of Ovarian Cancer
Zink, K. E., Dean, M., Burdette, J. E., & Sanchez, L. M. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00405 · Cited by 29
Reduced RBX1 expression induces chromosome instability and promotes cellular transformation in high-grade serous ovarian cancer precursor cells
Bungsy, M., Palmer, M. C. L., Jeusset, L. M., Neudorf, N. M., Lichtensztejn, Z., Nachtigal, M. W., & McManus, K. J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.051 · Cited by 34
Redefining the origin and evolution of ovarian cancer: a hormonal connection
Cardenas, C., Alvero, A. B., Yun, B. S., & Mor, G. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0209 · Cited by 29
Evaluating the progenitor cells of ovarian cancer: analysis of current animal models
King, S. M., & Burdette, J. E. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.7.435 · Cited by 28
Loss of PTEN in Fallopian Tube Epithelium Results in Multicellular Tumor Spheroid Formation and Metastasis to the Ovary
Dean, M., Jin, V., Bergsten, T. M., Austin, J. R., Lantvit, D. D., Russo, A., & Burdette, J. E. (2019) · Cancers · doi:10.3390/cancers11060884 · Cited by 28
Serous tubal intra‐epithelial carcinoma : what do we really know at this point?
VANG, R. S., & Shih, I. (2022) · Histopathology · doi:10.1111/his.14722 · Cited by 27
A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers
Cass, I. A., Walts, A. E., Barbuto, D. A., Lester, J., & Karlan, B. Y. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.07.084 · Cited by 27
Reconstitution of high-grade serous ovarian carcinoma from primary fallopian tube secretory epithelial cells
Nakamura, K., Nakayama, K., Ishikawa, N., Ishikawa, M., Sultana, R., Kiyono, T., & Kyo, S. (2017) · Oncotarget · doi:10.18632/oncotarget.23035 · Cited by 27
Ovarian Cancer Genetics: Subtypes and Risk Factors
Hirst, J. J., Crow, J., & Godwin, A. K. (2018) · InTech eBooks · doi:10.5772/intechopen.72705 · Cited by 29
Combined assembloid modeling and 3D whole-organ mapping captures the microanatomy and function of the human fallopian tube
Crawford, A. J., Forjaz, A., Bons, J., Bhorkar, I., Roy, T., Schell, D., Queiroga, V., Ren, K., Kramer, D., Huang, W., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp6285 · Cited by 27
TGFβ Controls Ovarian Cancer Cell Proliferation
Alsina‐Sanchís, E., Figueras, A., Lahiguera, Á., Gil-Martín, M., Pardo, B., Piulats, J. M., Martí, L., Ponce, J., Matías‐Guiu, X., Vidal, A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081658 · Cited by 26
Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells
Reavis, H. D., Gysler, S. M., McKenney, G. B., Knarr, M., Lusk, H. J., Rawat, P., Rendulich, H. S., Mitchell, M. A., Berger, D. S., Moon, J. S., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.170961 · Cited by 31
Self-citation
Early Preinvasive Lesions in Ovarian Cancer
Chene, G., Lamblin, G., Bail-Carval, K. L., Chabert, P., Bakrin, N., & Mellier, G. (2014) · BioMed Research International · doi:10.1155/2014/639252 · Cited by 26
Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence
Caruso, J. A., Karakaş, C., Zhang, J., Yi, M., Albarracin, C. T., Şahin, A. A., Bondy, M. L., Liu, J., Hunt, K. K., & Keyomarsi, K. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0497-4 · Cited by 26
Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three‐dimensional genetic models of ovarian carcinogenesis
Lawrenson, K., Mhawech-Fauceglia, P. Y., Worthington, J., Spindler, T. J., O'Brien, D. P., Lee, J. M., Spain, G., Sharifian, M., Wang, G., Darcy, K. M., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29197 · Cited by 25
The new face of ovarian cancer modeling: better prospects for detection and treatment
Karst, A. M., & Drapkin, R. (2011) · F1000 Medicine Reports · doi:10.3410/m3-22 · Cited by 25
Self-citation
Ultraminiature optical design for multispectral fluorescence imaging endoscopes
Tate, T. H., Keenan, M., Black, J. F., Utzinger, U., & Barton, J. K. (2017) · Journal of Biomedical Optics · doi:10.1117/1.jbo.22.3.036013 · Cited by 25
Mutation or Loss of p53 Differentially Modifies TGFβ Action in Ovarian Cancer
hAinmhire, E. Ó., Quartuccio, S. M., Cheng, W., Ahmed, R. A., King, S. M., & Burdette, J. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089553 · Cited by 25
A cell atlas of the human fallopian tube throughout the menstrual cycle and menopause
Weigert, M., Li, Y., Zhu, L., Eckart, H., Bajwa, P., Krishnan, R., Ackroyd, S. A., Lastra, R. R., Bilecz, A. J., Basu, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55440-2 · Cited by 26
Integrative Transcriptome Analyses of the Human Fallopian Tube: Fimbria and Ampulla—Site of Origin of Serous Carcinoma of the Ovary
Sowamber, R., Nelson, O. L., Dodds, L. V., DeCastro, V., Paudel, I., Milea, A. L., Considine, M., Cope, L., Pinto, A., Schlumbrecht, M. P., et al. (2020) · Cancers · doi:10.3390/cancers12051090 · Cited by 24
Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium
Archibald, K. M., Kulbe, H., Kwong, J., Chakravarty, P., Temple, J., Chaplin, T., Flak, M. B., McNeish, I. A., Deen, S., Brenton, J. D., et al. (2012) · Oncogene · doi:10.1038/onc.2011.653 · Cited by 24
Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous Carcinogenesis
Sapoznik, S., Bahar‐Shany, K., Brand, H., Pinto, Y., Gabay, O., Glick‐Saar, E., Dor, C., Zadok, O., Barshack, I., Zundelevich, A., et al. (2016) · Neoplasia · doi:10.1016/j.neo.2015.12.003 · Cited by 24
Self-citation
Spontaneous Transformation of Murine Oviductal Epithelial Cells: A Model System to Investigate the Onset of Fallopian-Derived Tumors
Endsley, M. P., Moyle-Heyrman, G., Karthikeyan, S., Lantvit, D. D., Davis, D. A., Wei, J., & Burdette, J. E. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00154 · Cited by 23
Small-Molecule–Mediated Stabilization of PP2A Modulates the Homologous Recombination Pathway and Potentiates DNA Damage-Induced Cell Death
Avelar, R. A., Armstrong, A. J., Carvette, G., Gupta, R., Puleo, N., Colina, J. A., Joseph, P. L., Sobeck, A. M., O’Connor, C. M., Raines, B., et al. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0880 · Cited by 25
Pelvic Inflammation and the Pathogenesis of Ovarian Cancer
McAlpine, J. N., Lisonkova, S., Joseph, K. S., & McComb, P. F. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000235 · Cited by 23
STAT3/PIAS3 Levels Serve as “Early Signature” Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube
Saini, U., Suarez, A. A., Naidu, S. K., Wallbillich, J. J., Bixel, K. L., Wanner, R. A., Bice, J., Kladney, R. D., Lester, J., Karlan, B. Y., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1671 · Cited by 23
Chromosomal Instability and mTORC1 Activation through PTEN Loss Contribute to Proteotoxic Stress in Ovarian Carcinoma
Chui, M. H., Doodnauth, S. A., Erdmann, N., Tiedemann, R. E., Sircoulomb, F., Drapkin, R., Shaw, P. H., & Rottapel, R. K. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3029 · Cited by 23
Self-citation
Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators
Moyle-Heyrman, G., Schipma, M. J., Dean, M., Davis, D. A., & Burdette, J. E. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0213-3 · Cited by 22
The Integration of Biological Pathway Knowledge in Cancer Genomics: A review of existing computational approaches
Varadan, V., Mittal, P., Vaske, C. J., & Benz, S. C. (2011) · IEEE Signal Processing Magazine · doi:10.1109/msp.2011.943037 · Cited by 22
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma
de Cristofaro, T., Palma, T. D., Soriano, A. A., Monticelli, A., Affinito, O., Cocozza, S., & Zannini, M. (2016) · Oncotarget · doi:10.18632/oncotarget.9740 · Cited by 22
Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium
Qiu, C., Lü, N., Wang, X., Zhang, Q., Yuan, C., Yan, S., Dongol, S., Li, Y., Sun, X., Sun, C., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.09.029 · Cited by 22
Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary
Gutkin, D. W., Shurin, M. R., Azher, M. A. E., Shurin, G. V., Velikokhatnaya, L., Prosser, D., Shin, N., Modugno, F., Stemmer, P. M., Elishaev, E., et al. (2019) · Cancer Biomarkers · doi:10.3233/cbm-190528 · Cited by 19
Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer
Galhenage, P. M., Zhou, Y., Perry, E., Loc, B., Fietz, K., Iyer, S., Reinhardt, F., Silva, T. D., Botchkarev, V. A., Chen, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113144 · Cited by 21
Dormant origin firing promotes head-on transcription-replication conflicts at transcription termination sites in response to BRCA2 deficiency
Goehring, L. J., Keegan, S., Lahiri, S., Xia, W., Kong, M., Jiménez-Sáinz, J., Gupta, D., Drapkin, R., Jensen, R. B., Smith, D. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48286-1 · Cited by 25
Self-citation
PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer
Modi, D., Tagare, R. D., Karthikeyan, S., Russo, A., Dean, M., Davis, D. A., Lantvit, D. D., & Burdette, J. E. (2016) · Oncogene · doi:10.1038/onc.2016.455 · Cited by 21
Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer
Henry, C. E., Emmanuel, C., Lambie, N., Loo, C. K. C., Kan, B., Kennedy, C. J., DeFazio, A., Hacker, N. F., & Ford, C. E. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.01.014 · Cited by 20
Role of the stem cell niche in the pathogenesis of epithelial ovarian cancers
Flesken‐Nikitin, A., Odai-Afotey, A. A., & Nikitin, A. Y. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.963435 · Cited by 20
Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion
Minopoli, M., Botti, G., Gigantino, V., Ragone, C., Sarno, S., Motti, M. L., Scognamiglio, G., Greggi, S., Scaffa, C., Roca, M. S., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1465-8 · Cited by 20
Loss of LKB1-NUAK1 signalling enhances NF-κB activity in a spheroid model of high-grade serous ovarian cancer
Buensuceso, A. V., Fritz, J. L., Collins, O. M., Valdés, Y. R., Borrelli, M. J., DiMattia, G. E., & Shepherd, T. G. (2022) · Scientific Reports · doi:10.1038/s41598-022-06796-2 · Cited by 18
Epidermal Growth Factor Induces Human Oviductal Epithelial Cell Invasion by Down-Regulating E-Cadherin Expression
Cheng, J., Chang, H., & Leung, P. C. K. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2751 · Cited by 18
Ovarian hormones through Wnt signalling regulate the growth of human and mouse ovarian cancer initiating lesions
Nagendra, P. B., Goad, J., Nielsen, S., Rassam, L., Lombard, J. M., Nahar, P., & Tanwar, P. S. (2016) · Oncotarget · doi:10.18632/oncotarget.11711 · Cited by 18
Gonadotropins Activate Oncogenic Pathways to Enhance Proliferation in Normal Mouse Ovarian Surface Epithelium
Hilliard, T. S., Modi, D., & Burdette, J. E. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14034762 · Cited by 17
Comparative transcriptome analysis links distinct peritoneal tumor spread types, miliary and non-miliary, with putative origin, tubes and ovaries, in high grade serous ovarian cancer
Auer, K., Bachmayr-Heyda, A., Aust, S., Grunt, T. W., & Pils, D. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.034 · Cited by 17
Silencing PTEN in the fallopian tube promotes enrichment of cancer stem cell-like function through loss of PAX2
Russo, A., Colina, J. A., Moy, J., Baligod, S., Czarnecki, A. A., Varughese, P., Lantvit, D. D., Dean, M., & Burdette, J. E. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03663-2 · Cited by 17
Specific Mesothelial Signature Marks the Heterogeneity of Mesenchymal Stem Cells From High-Grade Serous Ovarian Cancer
Verardo, R., Piazza, S., Klarić, E., Ciani, Y., Bussadori, G., Marzinotto, S., Mariuzzi, L., Cesselli, D., Beltrami, A. P., Mano, M., et al. (2014) · Stem Cells · doi:10.1002/stem.1791 · Cited by 16
Ovarian Cancer: Molecular Classification and Targeted Therapy
Ravindran, F., & Choudhary, B. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95967 · Cited by 16
3D dynamic cultures of HGSOC organoids to model innovative and standard therapies
Cavarzerani, E., Caligiuri, I., Bartoletti, M., Canzonieri, V., & Rizzolio, F. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1135374 · Cited by 15
CCAAT/enhancer binding protein delta (C/EBPδ) demonstrates a dichotomous role in tumour initiation and promotion of epithelial carcinoma
Sowamber, R., Chehade, R., Bitar, M., Dodds, L. V., Milea, A. L., Slomovitz, B. M., Shaw, P. A., & George, S. H. L. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.05.002 · Cited by 15
The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression
Escalona, R. M., Chan, E., Kannourakis, G., Findlay, J. K., & Ahmed, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020450 · Cited by 16
Multi-peptide nLC-PC-IDMS-SRM-based Assay for the quantification of biomarkers in the chicken ovarian cancer model
Andrews, G. L., Petitte, J. N., Muddiman, D. C., & Hawkridge, A. M. (2013) · Methods · doi:10.1016/j.ymeth.2013.04.004 · Cited by 14
MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor
Hałoń, A., Materna, V., Donizy, P., Matkowski, R., Rabczyński, J., Lage, H., & Surowiak, P. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2589-7 · Cited by 14
Epithelialization of mouse ovarian tumor cells originating in the fallopian tube stroma
Hua, Y., Choi, P., Trachtenberg, A. J., Ng, A. C., Kuo, W. P., Ng, S., Dinulescu, D. M., Matzuk, M. M., Berkowitz, R. S., & Ng, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11808 · Cited by 13
Current Preclinical Models of Ovarian Cancer
Tisato, E. K. V. (2015) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000220 · Cited by 13
Platelet-Derived Growth Factor in the Ovarian Follicle Attracts the Stromal Cells of the Fallopian Tube Fimbriae
Yeh, C.-H., Chen, P., Chen, C.-H., Hsu, C., Huang, R., Ding, D., & Chu, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158266 · Cited by 13
Complete salpingectomy versus tubal ligation during cesarean section: a systematic review and meta-analysis
Yang, M., Du, Y., & Hu, Y. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1690446 · Cited by 13
Plate-like Alginate Microparticles with Disulfiram–SPIO–Coencapsulation: An In Vivo Study for Combined Therapy on Ovarian Cancer
Bai, M., Yu, M.-H., Wang, T., Chen, S.-H., & Wang, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091348 · Cited by 13
Culture Models to Define Key Mediators of Cancer Matrix Remodeling
Fuller, E. S., & Howell, V. M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00057 · Cited by 12
Diagnostic and prognostic value of serum human epididymis protein 4 in patients with primary fallopian tube carcinoma
Mi, D., Zhang, Y.-X., Wang, C.-J., Feng, Q., Qi, P., & Chen, S. (2016) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13053 · Cited by 12
In-depth LC-MS/MS analysis of the chicken ovarian cancer proteome reveals conserved and novel differentially regulated proteins in humans
Nepomuceno, A. I., Shao, H., Jing, K., Ma, Y., Petitte, J. N., Idowu, M. O., Muddiman, D. C., Fang, X., & Hawkridge, A. M. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8862-4 · Cited by 12
Diseases of the Fallopian Tube and Paratubal Region
VANG, R. S. (2018) · Springer eBooks · doi:10.1007/978-1-4614-3165-7_11-2 · Cited by 12
New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research
Sherman, M. E., Guido, R. L., Wentzensen, N., Yang, H., Mai, P. L., & Greene, M. H. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.08.023 · Cited by 12
Sub-terahertz vibrational spectroscopy for microRNA based diagnostic of ovarian cancer
Globus, T. R., Sizov, I., Ferrance, J. P., Jazaeri, A. A., Bryant, J., Moyer, A., GELMONT, B. L., KESTER, M. A., & Bykhovski, A. (2016) · Convergent Science Physical Oncology · doi:10.1088/2057-1739/2/4/045001 · Cited by 12
A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting Drugs
Nagaraj, A. B., Joseph, P. L., Ponting, E., Federov, Y., Singh, S., Cole, A., Lee, W., Yoon, E., Baccarini, A., Scacheri, P. C., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.12.002 · Cited by 11
Self-citation
A Systems Biology Comparison of Ovarian Cancers Implicates Putative Somatic Driver Mutations through Protein-Protein Interaction Models
Yang, M. Q., & Elnitski, L. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163353 · Cited by 12
Pathophysiological and anatomical basis of lymphatic transit of cancer cells and role of the lymphatic system: a review of published literature
Matanes, E., & Gotlieb, W. H. (2021) · Chinese Clinical Oncology · doi:10.21037/cco-20-205 · Cited by 10
Distinct molecular signature of recurrent ovarian tumor cells isolated from the ascites of advanced-stage serous ovarian cancer patients
Latifi, A., Escalona, R. M., Quinn, M. A., Thompson, E. W., Findlay, J. K., & Ahmed, N. (2014) · Journal of Cancer Stem Cell Research · doi:10.14343/jcscr.2014.2e1006 · Cited by 9
Organoid culture of mouse fallopian tube epithelial stem cells with a thermo-reversible gelation polymer
Yunxiu, L., Wei, Y., Jiang, M., Tang, X., Huang, F., & Yang, X. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101622 · Cited by 9
Opportunistic salpingectomy between 2011 and 2016: a descriptive analysis
Hanley, G. E., Niu, J., Han, J., Fung, S., Bryant, H., Kwon, J. S., Huntsman, D. D., Finlayson, S. J., McAlpine, J. N., Miller, D. M., et al. (2022) · CMAJ Open · doi:10.9778/cmajo.20210219 · Cited by 9

Authors: Karst, A. M., Levanon, K., & Drapkin, R.
Affiliations: Harvard University (US)
Brigham and Women's Hospital (US)
ORCID: Levanon, Keren
Drapkin, Ronny
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2011-04-18
Volume: 108
Issue: 18
Pages: 7547-7552
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1017300108
PMC: PMC3088633
OpenAlex: W2071014344
Cited by: 280
References: 37
Citations by year: 2026: 5 · 2025: 11 · 2024: 6 · 2023: 14 · 2022: 9 · 2021: 19 · 2020: 12 · 2019: 22 · 2018: 22 · 2017: 11 · 2016: 25 · 2015: 28 · 2014: 30 · 2013: 27 · 2012: 26
FWCI: 34.30
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research
National Cancer Institute (P50CA105009)
Topics: Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Keywords: high-grade serous ovarian cancer, fallopian tube epithelium, secretory epithelial cells, carcinogenesis, cell transformation, hTERT immortalization, oncogenic Ras, c-Myc, p53, CDK4, Müllerian carcinoma, xenograft tumorigenicity, ovarian surface epithelium
MeSH terms: Antigens, Polyomavirus Transforming, Carcinoma, Cell Transformation, Neoplastic, Epithelial Cells, Fallopian Tubes, Female, Humans, Immunohistochemistry, Microscopy, Fluorescence, Ovarian Neoplasms, Tumor Stem Cell Assay, Blotting, Western, Carcinogenicity Tests, Telomerase, Cell Line, Tumor, Comparative Genomic Hybridization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Modeling high-grade serous ovarian carcinogenesis from the fallopian tube

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks